Novartis India Q4 profit falls 26 percent to Rs 20 crore

Novartis India's board has recommended a dividend of 200 per cent (Rs 10 per equity share of Rs 5 each) for the year ended March 31, 2019.

New Delhi: Drug firm Novartis India Thursday reported 26.21 per cent decline in net profit at Rs 19.53 crore for the quarter ended March 31, 2019.

The company posted a profit of Rs 26.47 crore in the year-ago period, Novartis India said in a BSE filing.

Revenue from operations for the latest quarter stood at Rs 110.38 crore as against Rs 125.32 crore in the same period of 2017-18.

Read Also: Novartis plans gene therapy price lower than $4 million to $5 million range

For the entire 2018-19, net profit was Rs 51.77 crore as compared to Rs 78.36 crore during the previous year.

Revenue from operations for the last fiscal stood at Rs 490.68 crore as against Rs 563.89 crore in 2017-18.

The company's board has recommended a dividend of 200 per cent (Rs 10 per equity share of Rs 5 each) for the year ended March 31, 2019.

Read Also: Japan: Novartis gets Government nod for cancer treatment Kymriah at cost of $305800